Filing Flows

Filing Flows › Comparisons › IMCR vs VISK

Immunocore Holdings vs Viskase Holdings: IMCR and VISK compared

Immunocore Holdings is the larger company: $102M of revenue in its latest quarter (Q3 2026) against $95.3M for Viskase Holdings (Q3 2026). Viskase Holdings is growing faster (+4% against -1% a year earlier). Viskase Holdings is more profitable, with an operating margin of -3.3% against -13.3%.

Immunocore Holdings vs Viskase Holdings, latest quarterImmunocore Holdings vs Viskase Holdings, latest quarterImmunocore Holdings (IMCR)Viskase Holdings (VISK)Revenue$102M$95.3MRevenue growth, Y/Y-1%+4%Operating margin-13.3%-3.3%Net margin-13.9%-6.8%

Where the money goes: IMCR and VISK

Immunocore Holdings (IMCR) · Q3 2026

Immunocore Holdings, Q3 2026: revenue $102M (-1% year over year), operating margin -13.3%, net loss $14.2M, operating cash flow $20.1M. The chart follows the revenue to costs, profit and cash.

Viskase Holdings (VISK) · Q3 2026

Viskase Holdings, Q3 2026: revenue $95.3M (+4% year over year), operating margin -3.3%, net loss $6.4M, operating cash flow $454K. The chart follows the revenue to costs, profit and cash.

Viskase Holdings revenue by segment, Q3 2026Viskase Holdings revenue by segment, Q3 2026Nojax$53.8MFibrous$22.5MPlastic$10.7MOther$3.3M
Immunocore Holdings (IMCR)Viskase Holdings (VISK)
Latest quarterQ3 2026Q3 2026
Revenue$102M$95.3M
Revenue growth, Y/Y-1%+4%
Operating margin-13.3%-3.3%
Net earnings−$14.2M−$6.4M
Net margin-13.9%-6.8%
Operating cash flow$20.1M$454K
Free cash flow$17.7M—
Market value$1.5B—
Analysts’ mean target$58.33—

Where the revenue comes from

Viskase Holdings

Questions

Which is bigger, Immunocore Holdings or Viskase Holdings?

Immunocore Holdings is the larger company: $102M of revenue in its latest quarter (Q3 2026) against $95.3M for Viskase Holdings (Q3 2026).

Is Immunocore Holdings or Viskase Holdings growing faster?

Viskase Holdings is growing faster (+4% against -1% a year earlier).

Which is more profitable, Immunocore Holdings or Viskase Holdings?

Viskase Holdings is more profitable, with an operating margin of -3.3% against -13.3%.

More: Immunocore Holdings earnings · how Immunocore Holdings makes money · Viskase Holdings earnings · how Viskase Holdings makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.